Stay updated on Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.

Latest updates to the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe name of the institution has been updated to include 'Université Catholique de Louvain', and the version number has been revised from v2.15.0 to v2.15.2.SummaryDifference0.4%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and criteria for a clinical trial on metastatic cancer, while retaining some key identifiers like the study code LUC-19-002 and the design model.SummaryDifference19%
- Check33 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check91 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check98 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.